AI Product

Proscia — Digital Pathology

Concentriq enterprise pathology platform with AI-native architecture, precision medicine AI portfolio, embeddings for foundation-model development, and real-world pathology image datasets…

Intelligence Summary

Product
  • Active
  • Verified public sources
  • Developer Proscia
  • Category Digital Pathology
  • Status Active
  • Latest update 2014: Proscia founded in Philadelphia by David West, Coleman Stavish, and Nathan Buchbinder.
  • Documentation Official page
  • Last reviewed Jul 2026
6 Technologies

Official product page

Target customer

Diagnostic laboratories, pharmaceutical R&D teams, and CROs digitizing pathology workflows and biomarker programs at enterprise scale.

Features & capabilities

Industries: AI in Healthcare; Digital Pathology

Related reports

Related insights

Overview

Concentriq enterprise pathology platform with AI-native architecture, precision medicine AI portfolio, embeddings for foundation-model development, and real-world pathology image datasets for research.

Product and company

Proscia — Digital Pathology is a verified product offering linked to the Brel Digital company profile for Proscia.

Use cases

Concentriq enterprise pathology platform with AI-native architecture, precision medicine AI portfolio, embeddings for foundation-model development, and real-world pathology image datasets for research.

Target customer

Diagnostic laboratories, pharmaceutical R&D teams, and CROs digitizing pathology workflows and biomarker programs at enterprise scale.

Technologies

Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics, Vector Database.

Sources and references

  • Official product / company source: https://proscia.com/press-release/proscia-launches-fifth-generation-of-concentriq
  • Supporting source: https://proscia.com/leadership/

Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.

Last reviewed

This product profile was last reviewed on 2026-07-14.

Correction request

If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.

Features and capabilities

  • Concentriq enterprise pathology platform with AI-native architecture, precision medicine AI portfolio, embeddings for foundation-model development, and real-world pathology image datasets for research.

Extracted from the linked company product description already verified on Brel. No capabilities were invented.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Enquire about this product profile

Messages are delivered to contact@breldigital.com.